US 10744116
Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas
granted A61KA61K31/337A61K31/385
Quick answer
US patent 10744116 (Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas) held by The Regents of the University of California expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/337, A61K31/385, A61K31/427, A61K39/39558